SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Edwards EB, Roberts JP, McBride MA, Schulak JA, Hunsicker LG. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Engl J Med. 1999; 341 (27): 20492053.
  • 2
    Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998; 280 (20): 17471751.
  • 3
    Gordon TA, Bowman HM, Bass EB, et al. Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J Am Coll Surg. 1999; 189 (1): 4656.
  • 4
    Sosa JA, Bowman HM, Gordon TA, et al. Importance of hospital volume in the overall management of pancreatic cancer. Ann Surg. 1998; 228 (3): 429438.
  • 5
    Patti MG, Corvera CU, Glasgow RE, Way LW. A hospital's annual rate of esophagectomy influences the operative mortality rate. J Gastrointest Surg. 1998; 2 (2): 186192.
  • 6
    Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg. 1999; 134 (1): 3035.
  • 7
    Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA. 1994; 271 (15): 11631168.
  • 8
    Roohan PJ, Bickell NA, Baptiste MS, Therriault GD, Ferrara EP, Siu AL. Hospital volume differences and five-year survival from breast cancer. Am J Public Health. 1998; 88 (3): 454457.
  • 9
    National Comprehensive Cancer Network. Update: NCCN practice guidelines for the treatment of breast cancer. Oncology (Huntington). 1999; 13 (5A): 4166.
  • 10
    Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000; 50 (1): 733.
  • 11
    Carlson RW, Goldstein LJ, Gradishar WJ, et al. NCCN breast cancer practice guidelines. The National Comprehensive Cancer Network. Oncology (Huntington). 1996; 10 (11 Suppl): 4775.
  • 12
    Olivotto A, Coldman AJ, Hislop TG, et al. Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol. 1997; 15 (1): 216222.
  • 13
    Guadagnoli E, Shapiro CL, Weeks JC, Gurwitz JH, Borbas C, Soumerai SB. The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines? Cancer. 1998; 83 (2): 302309.
  • 14
    Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999; 85 (5): 11041113.
  • 15
    Bjurstam N, Bjorneld L, Duffy SW, et al. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39–49 years at randomization. Cancer. 1997; 80 (11): 20912099.
  • 16
    Hislop TG, Worth AJ, Kan L, Rousseau E. Post screen-detected breast cancer within the Screening Mammography Program of British Columbia. Breast Cancer Res Treat. 1997; 42 (3): 235242.
  • 17
    Robertson FM, Romanow J, Otchy DP, Walters MJ. Effect of mass screening mammography on staging of carcinoma of the breast in women. Surg Gynecol Obstet. 1990; 171 (1): 5558.
  • 18
    Tabar L, Duffy SW, Vitak B, Chen HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer. 1999; 86 (3): 449462.
  • 19
    Devia A, Murray KA, Nelson EW. Stereotactic core needle biopsy and the workup of mammographic breast lesions. Arch Surg. 1997; 132 (5): 512515, discussion 515–517.
  • 20
    Kopans DB, Moore RH, McCarthy KA, et al. Positive predictive value of breast biopsy performed as a result of mammography: there is no abrupt change at age 50 years. Radiology. 1996; 200 (2): 357360.
  • 21
    Tran DQ, Wilkerson DK, Namm J, Zeis MA, Cottone FJ. Needle-localized breast biopsy for mammographic abnormalities: a community hospital experience. Am Surg. 1999; 65 (3): 283288.
  • 22
    Lein BC, Alex WR, Zebley DM, Pezzi CM. Results of needle localized breast biopsy in women under age 50. Am J Surg. 1996; 171 (3): 356359.
  • 23
    Alexander HR, Candela FC, Dershaw DD, Kinne DW. Needle-localized mammographic lesions. Results and evolving treatment strategy. Arch Surg. 1990; 125 (11): 14411444.
  • 24
    Bender JS, Magnuson TH, Smith-Meek MA, Ratner LE, Smith GW. Will stereotactic breast biopsy achieve results as good as current techniques? Am Surg. 1996; 62 (8): 637639, discussion 639–640.
  • 25
    Robertson CL. A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology. 1993; 187 (1): 7579.
  • 26
    Howe JR, Monsees B, Destouet J, Seib J, Dehner LP, Kraybill WG. Needle localization breast biopsy: a model for multidisciplinary quality assurance. J Surg Oncol. 1995; 58 (4): 233239.
  • 27
    Linver MN, Paster SB, Rosenberg RD, Key CR, Stidley CA, King WV. Improvement in mammography interpretation skills in a community radiology practice after dedicated teaching courses: 2-year medical audit of 38,633 cases. Radiology. 1992; 184 (1): 3943.
  • 28
    Moseson D. Audit of mammography in a community setting. Am J Surg. 1992; 163 (5): 544546.
  • 29
    Sickles EA, Ominsky SH, Sollitto RA, Galvin HB, Monticciolo DL. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Radiology. 1990; 175 (2): 323327.
  • 30
    Poplack SP, Tosteson AN, Grove MR, Wells WA, Carney PA. Mammography in 53,803 women from the New Hampshire mammography network. Radiology. 2000; 217 (3): 832840.
  • 31
    American Joint Committee on Cancer. AJCC cancer staging manual, 5th ed. New York: Lippincott-Raven, 1997.
  • 32
    Hewitt M, Simone JV. Ensuring quality cancer care. Washington, DC: National Academy Press, 1999: 256.
  • 33
    Wallace JE, Sayler C, McDowell NG, Moseley HS. The role of stereotactic biopsy in assessment of nonpalpable breast lesions. Am J Surg. 1996; 171 (5): 471473.
  • 34
    Johnston JA, Clee CZ. Analysis of 308 localisation breast biopsies in a New Zealand hospital. Australas Radiol. 1991; 35 (2): 148151.
  • 35
    Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998; 338 (16): 10891096.
  • 36
    Jamrozik K, Byrne MJ, Dewar JM, et al. The effect of mammographic screening on invasive breast cancer in Western Australia. Med J Aust. 2000; 172 (5): 203206.
  • 37
    Reeves MJ, Newcomb PA, Remington PL, Marcus PM. Determinants of breast cancer detection among Wisconsin (United States) women, 1988–1990. Cancer Causes Control. 1995; 6 (2): 103111.
  • 38
    Moody-Ayers SY, Wells CK, Feinstein AR. “Benign” tumors and “early detection” in mammography-screened patients of a natural cohort with breast cancer. Arch Intern Med. 2000; 160 (8): 11091115.
  • 39
    Bassett LW, Farria DM, Bansal S, Farquhar MA, Wilcox PA, Feig SA. Reasons for failure of a mammography unit at clinical image review in the American College of Radiology Mammography Accreditation Program. Radiology. 2000; 215 (3): 698702.
  • 40
    Linver MN, Osuch JR, Brenner RJ, Smith RA. The mammography audit: a primer for the mammography quality standards act (MQSA). Am J Roentgenol. 1995; 165 (1): 1925.
  • 41
    Dolan JT, Granchi TS, Miller CC III, Brunicardi FC. Low use of breast conservation surgery in medically indigent populations. Am J Surg. 1999; 178 (6): 470474.
  • 42
    Goel V, Olivotto I, Hislop TG, Sawka C, Coldman A, Holowaty EJ. Patterns of initial management of node-negative breast cancer in two Canadian provinces. British Columbia/Ontario Working Group. CMAJ. 1997; 156 (1): 2535.
  • 43
    Hislop TG, Olivotto IA, Coldman AJ, et al. Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia. Can J Public Health. 1996; 87 (6): 390394.
  • 44
    Kotwall CA, Covington DL, Rutledge R, Churchill MP, Meyer AA. Patient, hospital, and surgeon factors associated with breast conservation surgery. A statewide analysis in North Carolina. Ann Surg. 1996; 224 (4): 419426, discussion 426–429.
  • 45
    Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992; 326 (17): 11021107.
  • 46
    Ayanian JZ, Guadagnoli E. Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat. 1996; 40 (1): 6574.
  • 47
    Ries LAG, Kosary CL, Hankey BF, Miller BA, Edwards BK. SEER cancer statistics review, 1973–1996. Bethesda: National Cancer Institute, 1999.
  • 48
    Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001; 345 (3): 181188.
  • 49
    Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA. 2000; 284 (23): 30283035.